Latest News

July 25, 2012
John Greenspan, BDS, PhD, considers himself naturally curious. When he started seeing a rare form of cancer of the lymphatoid system in young San Francisco men during the early 1980s, he was intrigued.
July 24, 2012
Population-wide levels of HIV virus dropped substantially between 2011 and May 2012 in a rural part of southwestern Uganda, the site of two community health campaigns led by doctors at the University of California, San Francisco (UCSF), San Francisco General Hospital and Trauma Center (SFGH) and Makerere University in Kampala, Uganda.
July 24, 2012
Bill and Hillary Clinton, Sharon Stone, Kathleen Sebelius, Bill Gates and Elton John are a few of the headliners to speak this week at AIDS 2012, the XIX International AIDS Conference, which runs through July 27 in Washington, D.C.
July 23, 2012
In January 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.
July 23, 2012
A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.
July 23, 2012
Warner C. Greene, MD, a professor of medicine, microbiology and immunology at UCSFwho directs virology and immunology research at the UCSF-affiliated Gladstone Institutes, has joined with other global AIDS experts to release a locally affordable version of the world’s leading AIDS medical textbook.
July 21, 2012
Researchers from the University of California, San Francisco (UCSF) and Makerere University in Uganda have used hair and blood samples from three-month old infants born to HIV-positive mothers to measure the uninfected babies’ exposure — both in the womb and from breast-feeding — to antiretroviral medications their mothers were taking. The results, they said, are surprising.
July 20, 2012
The AIDS drug Truvada, approved this week for prevention of HIV infection in uninfected people at high risk, may benefit many uninfected women whose male partners have HIV, including pregnant women, who may be at higher risk.
July 20, 2012
A perspective published in the New England Journal of Medicine this week by professors at UCSF and the Johns Hopkins University asserts that it is now possible to begin to end the AIDS epidemic by widely and strategically applying existing tools.
July 20, 2012
Diane Havlir, MD, professor of medicine at UCSF and the chief of the UCSF Division of HIV/AIDS and Positive Health Program at San Francisco General Hospital and Trauma Center (SFGH), talks about the XIX international AIDS Conference in Washington, D.C. and her role as co-chair.

Pages